APH1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.5131999986373E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.16780000406436E-08 |
Normal-vs-Stage2 |
9.71229999999768E-05 |
Normal-vs-Stage3 |
3.78700000025489E-07 |
Normal-vs-Stage4 |
2.78710000001237E-06 |
Stage1-vs-Stage2 |
7.726200E-01 |
Stage1-vs-Stage3 |
8.205500E-02 |
Stage1-vs-Stage4 |
2.593500E-02 |
Stage2-vs-Stage3 |
2.786600E-01 |
Stage2-vs-Stage4 |
4.054500E-02 |
Stage3-vs-Stage4 |
3.014200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.97030000040444E-07 |
Normal-vs-AfricanAmerican |
1.03760000036424E-07 |
Normal-vs-Asian |
1.463850E-03 |
Caucasian-vs-AfricanAmerican |
4.598000E-01 |
Caucasian-vs-Asian |
2.665800E-01 |
AfricanAmerican-vs-Asian |
3.063800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.64840055336424E-10 |
Normal-vs-Female |
4.386700E-04 |
Male-vs-Female |
8.769800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.196790E-04 |
Normal-vs-Extreme_Weight |
1.26440000003392E-06 |
Normal-vs-Obese |
3.248099999964E-06 |
Normal-vs-Extreme_Obese |
1.76129999995833E-06 |
Normal_Weight-vs-Extreme_Weight |
4.119400E-01 |
Normal_Weight-vs-Obese |
7.976400E-01 |
Normal_Weight-vs-Extreme_Obese |
7.654300E-02 |
Extreme_Weight-vs-Obese |
5.075600E-01 |
Extreme_Weight-vs-Extreme_Obese |
2.331200E-01 |
Obese-vs-Extreme_Obese |
2.202600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.84620000012836E-07 |
Normal-vs-Age(41-60Yrs) |
1.79900999999205E-05 |
Normal-vs-Age(61-80Yrs) |
1.97270000334981E-08 |
Normal-vs-Age(81-100Yrs) |
1.476470E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.120280E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.333500E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.742360E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.560600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.473800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.496200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.3325000000064E-06 |
Normal-VS-Type2 PRCC |
1.03149999652885E-08 |
Normal-VS-KIRP CIMP |
1.17220000039886E-07 |
Normal-VS-Unclassified PRCC |
4.617300E-03 |
Type1 PRCC-VS-Type2 PRCC |
2.957600E-01 |
Type1 PRCC-VS-KIRP CIMP |
2.32799999999589E-05 |
Type1 PRCC-VS-Unclassified PRCC |
7.513500E-02 |
Type2 PRCC-VS-KIRP CIMP |
1.001620E-03 |
Type2 PRCC-VS-Unclassified PRCC |
1.816170E-02 |
KIRP CIMP-VS-Unclassified PRCC |
1.551400E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.30769999776115E-08 |
Normal-vs-N1 |
3.17139980943182E-10 |
Normal-vs-N2 |
7.519100E-03 |
N0-vs-N1 |
7.542200E-03 |
N0-vs-N2 |
4.364800E-01 |
N1-vs-N2 |
6.401400E-01 |
|
|